{"id":30493,"date":"2020-10-09T12:00:00","date_gmt":"2020-10-09T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/le-president-trump-recoit-un-traitement-regeneron\/"},"modified":"2020-10-09T12:00:00","modified_gmt":"2020-10-09T12:00:00","slug":"le-president-trump-recoit-un-traitement-regeneron","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/le-president-trump-recoit-un-traitement-regeneron\/","title":{"rendered":"Le pr\u00e9sident Trump re\u00e7oit un traitement Regeneron"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1210 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<p>Le monde a \u00e9t\u00e9 secou\u00e9 par la nouvelle que l&#8217;homme le plus puissant de la plan\u00e8te a \u00e9galement \u00e9t\u00e9 test\u00e9 positif \u00e0 la COVID-19. Le pr\u00e9sident Trump a \u00e9t\u00e9 admis au Walter Reed National Medical Centre, le plus grand centre m\u00e9dical militaire du monde, avec des sympt\u00f4mes significatifs de la COVID-19. <\/p>\n<p>Le Dr Christos Kyratsous, vice-pr\u00e9sident de la recherche sur les maladies infectieuses et le secteur viral chez Regeneron, explique le long processus de d\u00e9veloppement chez Regeneron d&#8217;un cocktail de deux anticorps monoclonaux tr\u00e8s prometteurs \u2013 appel\u00e9 Th\u00e9rapie Regeneron Cough II \u2013 qui se lie \u00e0 la surface du virus et emp\u00eache le virus d&#8217;infecter d&#8217;autres cellules. L&#8217;\u00e9quipe m\u00e9dicale du pr\u00e9sident Trump a demand\u00e9 \u00e0 Regeneron de fournir ces deux anticorps. <\/p>\n<p>Ce qui a \u00e9t\u00e9 annonc\u00e9 jusqu&#8217;\u00e0 pr\u00e9sent, ce sont les donn\u00e9es du groupe de personnes test\u00e9es positives \u00e0 la COVID-19 mais pas encore hospitalis\u00e9es, o\u00f9 l&#8217;administration des anticorps entra\u00eene une baisse prononc\u00e9e de la charge virale. La prochaine \u00e9tape pour Regeneron est de mener des tests tr\u00e8s rigoureux dans le cadre d&#8217;essais cliniques pour voir comment ce cocktail m\u00e9dicamenteux fonctionne et quels sont les patients qui peuvent en b\u00e9n\u00e9ficier. <\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1211 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"Lecteur vid\u00e9o YouTube\" src=\"https:\/\/www.youtube.com\/embed\/9iqjfopzHJ4?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Le monde a \u00e9t\u00e9 secou\u00e9 par la nouvelle que l&#8217;homme le plus puissant de la plan\u00e8te a \u00e9galement \u00e9t\u00e9 test\u00e9 positif \u00e0 la COVID-19. Le pr\u00e9sident Trump a \u00e9t\u00e9 admis au Walter Reed National Medical Centre, le plus grand centre m\u00e9dical militaire du monde, avec des sympt\u00f4mes significatifs de la COVID-19. Le Dr Christos Kyratsous, vice-pr\u00e9sident de la recherche sur les maladies infectieuses et le secteur viral chez Regeneron, explique le long processus de d\u00e9veloppement chez Regeneron d&#8217;un cocktail de deux anticorps monoclonaux tr\u00e8s prometteurs \u2013 appel\u00e9 Th\u00e9rapie Regeneron Cough II \u2013 qui se lie \u00e0 la surface du virus et emp\u00eache le virus d&#8217;infecter d&#8217;autres cellules. L&#8217;\u00e9quipe m\u00e9dicale du pr\u00e9sident Trump a demand\u00e9 \u00e0 Regeneron de fournir ces deux anticorps. Ce qui a \u00e9t\u00e9 annonc\u00e9 jusqu&#8217;\u00e0 pr\u00e9sent, ce sont les donn\u00e9es du groupe de personnes test\u00e9es positives \u00e0 la COVID-19 mais pas encore hospitalis\u00e9es, o\u00f9 l&#8217;administration des anticorps entra\u00eene une baisse prononc\u00e9e de la charge virale. La prochaine \u00e9tape pour Regeneron est de mener des tests tr\u00e8s rigoureux dans le cadre d&#8217;essais cliniques pour voir comment ce cocktail m\u00e9dicamenteux fonctionne et quels sont les patients qui peuvent en b\u00e9n\u00e9ficier.<\/p>\n","protected":false},"author":1,"featured_media":30504,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[169],"tags":[171,301],"class_list":["post-30493","news","type-news","status-publish","has-post-thumbnail","hentry","category-emissions-dactualite-euforea","tag-actualites-euforea","tag-covid-19"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Le pr\u00e9sident Trump re\u00e7oit un traitement Regeneron - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/news\/le-president-trump-recoit-un-traitement-regeneron\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le pr\u00e9sident Trump re\u00e7oit un traitement Regeneron\" \/>\n<meta property=\"og:description\" content=\"Le monde a \u00e9t\u00e9 secou\u00e9 par la nouvelle que l&#8217;homme le plus puissant de la plan\u00e8te a \u00e9galement \u00e9t\u00e9 test\u00e9 positif \u00e0 la COVID-19. Le pr\u00e9sident Trump a \u00e9t\u00e9 admis au Walter Reed National Medical Centre, le plus grand centre m\u00e9dical militaire du monde, avec des sympt\u00f4mes significatifs de la COVID-19. Le Dr Christos Kyratsous, vice-pr\u00e9sident de la recherche sur les maladies infectieuses et le secteur viral chez Regeneron, explique le long processus de d\u00e9veloppement chez Regeneron d&#8217;un cocktail de deux anticorps monoclonaux tr\u00e8s prometteurs \u2013 appel\u00e9 Th\u00e9rapie Regeneron Cough II \u2013 qui se lie \u00e0 la surface du virus et emp\u00eache le virus d&#8217;infecter d&#8217;autres cellules. L&#8217;\u00e9quipe m\u00e9dicale du pr\u00e9sident Trump a demand\u00e9 \u00e0 Regeneron de fournir ces deux anticorps. Ce qui a \u00e9t\u00e9 annonc\u00e9 jusqu&#8217;\u00e0 pr\u00e9sent, ce sont les donn\u00e9es du groupe de personnes test\u00e9es positives \u00e0 la COVID-19 mais pas encore hospitalis\u00e9es, o\u00f9 l&#8217;administration des anticorps entra\u00eene une baisse prononc\u00e9e de la charge virale. La prochaine \u00e9tape pour Regeneron est de mener des tests tr\u00e8s rigoureux dans le cadre d&#8217;essais cliniques pour voir comment ce cocktail m\u00e9dicamenteux fonctionne et quels sont les patients qui peuvent en b\u00e9n\u00e9ficier.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/news\/le-president-trump-recoit-un-traitement-regeneron\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/le-president-trump-recoit-un-traitement-regeneron\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/le-president-trump-recoit-un-traitement-regeneron\\\/\",\"name\":\"Le pr\u00e9sident Trump re\u00e7oit un traitement Regeneron - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/le-president-trump-recoit-un-traitement-regeneron\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/le-president-trump-recoit-un-traitement-regeneron\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/President20Trump20Receives20Regeneron20Treatment.png\",\"datePublished\":\"2020-10-09T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/le-president-trump-recoit-un-traitement-regeneron\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/news\\\/le-president-trump-recoit-un-traitement-regeneron\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/le-president-trump-recoit-un-traitement-regeneron\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/President20Trump20Receives20Regeneron20Treatment.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/President20Trump20Receives20Regeneron20Treatment.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/le-president-trump-recoit-un-traitement-regeneron\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Le pr\u00e9sident Trump re\u00e7oit un traitement Regeneron\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Le pr\u00e9sident Trump re\u00e7oit un traitement Regeneron - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/news\/le-president-trump-recoit-un-traitement-regeneron\/","og_locale":"fr_FR","og_type":"article","og_title":"Le pr\u00e9sident Trump re\u00e7oit un traitement Regeneron","og_description":"Le monde a \u00e9t\u00e9 secou\u00e9 par la nouvelle que l&#8217;homme le plus puissant de la plan\u00e8te a \u00e9galement \u00e9t\u00e9 test\u00e9 positif \u00e0 la COVID-19. Le pr\u00e9sident Trump a \u00e9t\u00e9 admis au Walter Reed National Medical Centre, le plus grand centre m\u00e9dical militaire du monde, avec des sympt\u00f4mes significatifs de la COVID-19. Le Dr Christos Kyratsous, vice-pr\u00e9sident de la recherche sur les maladies infectieuses et le secteur viral chez Regeneron, explique le long processus de d\u00e9veloppement chez Regeneron d&#8217;un cocktail de deux anticorps monoclonaux tr\u00e8s prometteurs \u2013 appel\u00e9 Th\u00e9rapie Regeneron Cough II \u2013 qui se lie \u00e0 la surface du virus et emp\u00eache le virus d&#8217;infecter d&#8217;autres cellules. L&#8217;\u00e9quipe m\u00e9dicale du pr\u00e9sident Trump a demand\u00e9 \u00e0 Regeneron de fournir ces deux anticorps. Ce qui a \u00e9t\u00e9 annonc\u00e9 jusqu&#8217;\u00e0 pr\u00e9sent, ce sont les donn\u00e9es du groupe de personnes test\u00e9es positives \u00e0 la COVID-19 mais pas encore hospitalis\u00e9es, o\u00f9 l&#8217;administration des anticorps entra\u00eene une baisse prononc\u00e9e de la charge virale. La prochaine \u00e9tape pour Regeneron est de mener des tests tr\u00e8s rigoureux dans le cadre d&#8217;essais cliniques pour voir comment ce cocktail m\u00e9dicamenteux fonctionne et quels sont les patients qui peuvent en b\u00e9n\u00e9ficier.","og_url":"https:\/\/www.euforea.org\/news\/le-president-trump-recoit-un-traitement-regeneron\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/news\/le-president-trump-recoit-un-traitement-regeneron\/","url":"https:\/\/www.euforea.org\/news\/le-president-trump-recoit-un-traitement-regeneron\/","name":"Le pr\u00e9sident Trump re\u00e7oit un traitement Regeneron - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/news\/le-president-trump-recoit-un-traitement-regeneron\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/news\/le-president-trump-recoit-un-traitement-regeneron\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/President20Trump20Receives20Regeneron20Treatment.png","datePublished":"2020-10-09T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/news\/le-president-trump-recoit-un-traitement-regeneron\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/news\/le-president-trump-recoit-un-traitement-regeneron\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/news\/le-president-trump-recoit-un-traitement-regeneron\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/President20Trump20Receives20Regeneron20Treatment.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/President20Trump20Receives20Regeneron20Treatment.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/news\/le-president-trump-recoit-un-traitement-regeneron\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"Le pr\u00e9sident Trump re\u00e7oit un traitement Regeneron"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/30493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=30493"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/30493\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/30504"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=30493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=30493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=30493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}